Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Eli Lilly and Company
Pamphlets and handbills describing the treatment of diabetes and advertising insulin; also, pamphlets, handbills, and a form letter advertising pharmaceutical, including diphtheria antitoxin, Coco-Santal Compound (a urinary antiseptic containing sandalwood oil), Sodium amytal (a barbiturate sedative) and Ilotycin (brand of erythromycin, an antibiotic). A anatomical demonstartor booklet.
Eli Lilly and Beyond
Introduction --International legal framework --Eli Lilly v. Canada : facts and proceedings --"Promise utility doctrine" --Fair and equitable treatment standard and legitimate expectations --Legitimate expectations, intellectual property rights and international property law framework : Eli Lilly and beyond --Is conformity with international intellectual property norms enough? --Conclusions.
Eli Lilly, a Life, 1885-1977
The story of the Dudley Observatory is here told in detail, from its beginning in 1851 through eight years of tragicomic conflict. The author argues that differing perceptions of authority, responsibility, and accountability lie at the heart of the controversy and do much to explain relationships between nineteenth-century American scientists and the larger community. A biography of the drug magnate based on personal and business papers and interviews with people who knew him. Chronicles his early life and education, his business career, and his later interest in archaeology and history. Published for the Indiana Historical Society by IUP. Annotation copyrighted by Book News, Inc., Portland, OR
Next Generation Performance Management
There is no HR-related topic more popular in the business press than performance management (PM). There has been an explosion in writing on this topic in the past 5 years, condemning it as a failure and calling for fundamental change. The vast majority of organizations use the same basic process which I call “Last Generation Performance Management” or PM 1.0 for short. Despite widespread agreement that PM 1.0 is failing, few companies have abandoned it or made fundamental changes to it. While everyone agrees it is broken, few agree on how to fix it. Companies continue to tinker with their systems, making incremental changes every few years with no lasting improvement in effectiveness. Em...
The Zyprexa Papers
On December 17, 2006, The New York Times began a series of front-page stories about documents obtained from Alaska lawyer Jim Gottstein, showing Eli Lilly had concealed that its top-selling drug caused diabetes and other life-shortening metabolic problems. The "Zyprexa Papers," as they came to be known, also showed Eli Lilly was illegally promoting the use of Zyprexa on children and the elderly, with particularly lethal effects. Although Mr. Gottstein believes he obtained the Zyprexa Papers legally, the United States District Court for the Eastern District of New York in Brooklyn decided he had conspired to steal the documents, and Eli Lilly threatened Mr. Gottstein with criminal contempt charges. In The Zyprexa Papers, Mr. Gottstein gives a riveting first-hand account of what really happened, including new details about how a small group of psychiatric survivors spread the Zyprexa Papers on the Internet untraceably. All of this within a gripping, plain-language explanation of complex legal maneuvering and his battles on behalf of Bill Bigley, the psychiatric patient whose ordeal made possible the exposure of the Zyprexa Papers.
Formulation and Analytical Development for Low-Dose Oral Drug Products
There are unique challenges in the formulation, manufacture, analytical chemistry, and regulatory requirements of low-dose drugs. This book provides an overview of this specialized field and combines formulation, analytical, and regulatory aspects of low-dose development into a single reference book. It describes analytical methodologies like dissolution testing, solid state NMR, Raman microscopy, and LC-MS and presents manufacturing techniques such as granulation, compaction, and compression. Complete with case studies and a discussion of regulatory requirements, this is a core reference for pharmaceutical scientists, regulators, and graduate students.
Post-Authorization Safety Studies of Medicinal Products
Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questio...
Absorbent Polymer Technology
In recent years, there has been a veritable explosion of research and development in consumer-oriented fields that utilize polymeric materials which absorb large amounts of water. These fields encompass the preparation, characterization and commercialization of separation systems, pharmaceutical and personal care products such as infant diapers, feminine products, incontinence products and many other related areas. The polymeric materials utilized in these applications are known as absorbent or superabsorbent materials because of their ability to swell rapidly and to retain large volumes of water, urine and other biological fluids.The aim of this book is to introduce the fundamentals of poly...
Clinical Guide to Antineoplastic Therapy
Get the latest information on antineoplastic use and patient care when you purchase your copy of the essential chemotherapy resource for cancer-care professionals. Newly updated, revised, and expanded, the third edition of the Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook serves as an up-to-date reference for clinicians at every level from students and novices to the most seasoned nurses and other healthcare professionals involved in the care of patients receiving chemotherapy. Edited by Mary Magee Gullatte, this comprehensive guide features chapters on the fundamentals of antineoplastic therapy, commonly used regimens for specific cancers, clinical trials, reimbursement for chemotherapy, botanicals and other complementary and alternative therapies, vascular access devices, and symptom management, as well as an easy-to-use A Z guide of more than 150 chemotherapy, biotherapy, and hormonal therapy agents. New to this edition are chapters on patient navigati
